Dossier Hub

glp-1

Open full archive

Curated coverage for glp-1 with top developments, timeline context, and connected threads.

Lead CoverageScience02/04/2026, 15:47:07

The Real Reason Why Most People Who Lose Weight Gain It Back

90% of people who lose significant weight regain it within 5 years. New research reveals the specific biological mechanisms that make this almost inevitable — and what GLP-1 drugs do differently.

EuroBulletin24 Editorial Desk | Linked source

Dossier Timeline

4 updates
Economy02/04/2026, 15:46:21

The Protein Rush: Why Every Food Company Is Racing to Put More Protein in Your Food

Protein-enriched products are flooding the market as GLP-1 drug users and longevity-focused consumers drive demand. Here is the science behind protein's growing status and who is profiting.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:11

GLP-1 Drugs Are Helping People Stop Drinking — The Addiction Science Nobody Expected

Patients on Ozempic and similar drugs are spontaneously reporting reduced alcohol cravings and consumption. Here is the neuroscience behind why weight-loss drugs might treat addiction.

EuroBulletin24 Editorial Desk | Linked source

Economy02/04/2026, 15:45:58

The GLP-1 Drugs Are Making People Eat Less of Everything — What Food Companies Are Doing About It

Ozempic users eat significantly less. With millions on GLP-1 drugs, food companies are reformulating products for smaller servings. Here is the specific business transformation happening.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:45:50

The Drug That Was Supposed to Kill Diabetes Just Got Approved for Something Nobody Expected

GLP-1 drugs like Ozempic won FDA approvals for addiction, kidney disease, and heart failure in 2026. Here is the full science behind what these drugs are actually doing to the human body.

EuroBulletin24 Editorial Desk | Linked source